Related Experiment Video
Updated: Apr 10, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Clinical Controversies in Aerosol Therapy for Infants and Children
1Department of Pediatrics, Seattle Children's Hospital, and the Center for Developmental Therapeutics, Seattle Children's Hospital Research Institute, Seattle, Washington. robert.diblasi@seattlechildrens.org.
Insights
Optimizing aerosol drug delivery for pediatric patients requires specialized nebulizer technology and interfaces due to unique airway anatomy and breathing patterns in children. This review explores advancements and clinical debates in pediatric respiratory care.
Area of Science:
- Pediatric Respiratory Care
- Aerosol Drug Delivery Science
- Medical Device Technology
Background:
- Pediatric patients present unique challenges for aerosol therapy, including distinct airway anatomy, breathing patterns, and difficulty adhering to treatments.
- Effective aerosol drug delivery is crucial for pediatric respiratory care but remains technically demanding for clinicians.
Purpose of the Study:
- To review current research on pediatric nebulizer and interface devices for safe and efficient aerosol drug delivery.
- To discuss clinical controversies and debates in pediatric aerosol science, informing best practices.
Main Methods:
- Literature review focusing on pediatric nebulizer technology, interface devices, and aerosol delivery methods.
- Analysis of clinical controversies including crying vs. resting infants, inhaler types, continuous nebulization, and ventilation strategies.
Main Results:
- Advancements in nebulizer technology offer improved aerosol delivery options for pediatric patients.
- Key areas of debate include optimal drug delivery methods and device performance during various ventilation modes.
Conclusions:
- Tailored nebulizer and interface devices are essential for optimizing aerosol therapy in children.
- Addressing clinical controversies and leveraging technological advancements can enhance the safety and efficacy of pediatric respiratory treatments.
Abstract:
Pediatric patients are different from adult patients with respect to airway anatomy and breathing patterns. They are also incapable of following commands and often reject breathing treatments. For these reasons, aerosol drug delivery is one of the most technically challenging aspects for clinicians providing respiratory care to young children. Improvements in nebulizer technology have provided better delivery options for pediatric patients. This review highlights research related to pediatric nebulizer and interface devices and how they can be used to provide the safest and most efficient treatments with the array of treatment delivery options. Also addressed are clinical controversies and debates in pediatric aerosol science, including drug delivery in crying versus resting infants, pressurized metered-dose inhalers and small-volume nebulizers for bronchodilator administration, continuous nebulization, noninvasive drug delivery options, and optimization of nebulizer performance during infant and large pediatric conventional and high-frequency ventilation.
Related Concept Videos
Inhaled Medications
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

